TSLA•benzinga•
DOGE Reportedly Fires FDA Staff Reviewing Elon Musk's Neuralink: 'We Should Be Worried About The Whole Trial,' Says Former Official
Summary
Several U.S. Food and Drug Administration (FDA) employees involved in the review of Tesla (NASDAQ: TSLA) Chief, Elon Musk's private brain implant company, Neuralink, were dismissed over the weekend.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 19, 2025 by benzinga